Top

Published in:

Open Access 01-07-2012 | Poster presentation

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)

Authors: Ken-ichi Yamaguchi, Mitsumasa Kishimoto, Masato Okada

Published in: Pediatric Rheumatology | Special Issue 1/2012

Excerpt

TNF inhibitors are established treatment for poly-juvenile idiopathic arthritis (pJIA), but there are needs of alternative therapy for refractory patients. Tocilizumab (TCZ) has been widely used for rheumatoid arthritis (RA) in adults, and the effectiveness for systemic JIA has been well-documented. However, the experience on pJIA is limited. We compared the clinical courses of our patients of RA and pJIA to estimate the effectiveness of TCZ. …

Title: Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)
Authors: Ken-ichi Yamaguchi
Mitsumasa Kishimoto
Masato Okada
Publication date: 01-07-2012
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2012
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-10-S1-A55

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA)

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2012

The primary complement components contained in circulating immune complexes in oligoarticular and polyarticular juvenile idiopathic arthritis patient sera are C1q and C4: evidence of classical complement activation

The juvenile systemic sclerosis clinic: an interdisciplinary approach

Recurrent meningoencephalitis and hyponatremia in childhood neurosarcoidosis

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous

Descriptive analysis of herpes zoster in childhood-onset systemic lupus erythematosus

Small practice effects on neurocognitive testing – markers of early cognitive impairment among adolescents with SLE?